AmericanPeptide
Therapeutic Class Review · Melanocortin System

Melanocortin Agonist
Research Hub

Exploring MC1R–MC5R receptor agonists — from FDA-approved therapeutics to next-generation candidates. 3 approved therapies · 5 receptor subtypes · expanding pipeline.

3FDA-Approved Therapies
5Receptor Subtypes
3+Pipeline Candidates

Approved Therapeutics

FDA-Approved Melanocortin Agonists

Three approved therapies targeting the melanocortin system across distinct therapeutic indications

Setmelanotide

FDA 2020

IMCIVREE

MC4R

Indication: Obesity from POMC, PCSK1, or LEPR deficiency

Ask AI

Bremelanotide

FDA 2019

Vyleesi / PT-141

MC4R + MC1R

Indication: Hypoactive sexual desire disorder in premenopausal women

Ask AI

Afamelanotide

FDA 2019

Scenesse

MC1R

Indication: Erythropoietic protoporphyria phototoxicity

Ask AI

Receptor Biology

Melanocortin Receptor Map

Five distinct receptor subtypes with different tissue distributions, functions, and therapeutic development status

Approved
Clinical Trials
Preclinical
MC1RApproved

Location

Skin, melanocytes, immune cells

Function

Pigmentation (eumelanin synthesis), UV protection, immune modulation

Key agonist

Afamelanotide (Scenesse)

MC2RPreclinical

Location

Adrenal cortex

Function

Adrenal steroidogenesis — sole known receptor for ACTH

Key agonist

None approved

MC3RClinical Trials

Location

Brain, gut, immune cells

Function

Energy homeostasis, anti-inflammatory signaling, feeding behavior

Key agonist

Under investigation

MC4RApproved

Location

Hypothalamus, limbic system

Function

Appetite, energy expenditure, sexual function, autonomic control

Key agonist

Setmelanotide, Bremelanotide

MC5RPreclinical

Location

Exocrine glands, skin, skeletal muscle

Function

Exocrine secretion, sebum production, immune function

Key agonist

None approved

Receptor Binding Selectivity Profiles

Relative binding activity across MC1R–MC5R for each FDA-approved agonist

Normalized relative values (0–100) for visualization only — not exact Ki or EC50 data.

Emerging Candidates

Melanocortin Agonist Pipeline

Next-generation candidates advancing toward and through clinical development as of May 2026

◎ Planned

PL7737

Palatin Technologies

Obesity

MC4ROral small moleculePhase 1 planned 2026
◎ Planned

Next-gen MC4R peptide agonists

Palatin Technologies

Hypothalamic obesity

MC4ROnce-weekly subcutaneous peptidePhase 1 mid-2026
● Active

Setmelanotide (expanded indications)

Rhythm Pharmaceuticals

Additional genetic obesity subtypes

MC4RDaily subcutaneousPhase 3 ongoing

Research Sourcing

Where to Source

Trust-ranked vendors for PT-141, melanotan-1, and related melanocortin research peptides — ranked by purity documentation, not commission

Where to source · featured partner (paid)

ABSIM Peptides

40/100
Vendor-claimed testing

20% off your order.

Vetted by relationship as well as paperwork. We know the US-based operators directly, and they ship stateside and accept major credit cards — a card processor underwrote this business, so your chargeback protection rides along with every order.

ABSIM Peptidesvs. typical vendor
  • Who runs it

    Known US operators, vetted directly

    Anonymous storefront

  • Ships from

    Stateside

    Often overseas

  • Payment

    Major credit cards

    Crypto / wire only

  • Buyer protection

    Card-processor underwritten — chargeback protection on every order

    None (crypto is final)

  • Testing & COA

    COA published per product (not lot-matched)

    COA published per product (not lot-matched)

The fine print

Checkout requires an account; returns are accepted within 7 days with photos.

Visit ABSIM Peptides

Discount applies automatically — or enter AMERICANPEPTIDE at checkout.

Compare all 3 vetted sources

Affiliate disclosure. AmericanPeptide does not sell peptides. This is an independent third-party vendor, and we may earn a commission if you register or buy through this link — at no extra cost to you. Listing and ranking are based on published transparency signals, never on commission; where a card is labeled “Featured partner,” that placement is paid, and it buys position rather than a better score.

Platform Tools

Continue Your Research

Use AmericanPeptide's integrated tools to go deeper into melanocortin biology and therapeutic development